Researchers testing several heart, anti-platelet drugs for COVID-19 patients

Many COVID-19 patients are participating in trials and studies evaluating whether heart and anti-platelet drugs are effective treatments, according to The Wall Street Journal.

Some researchers argue that COVID-19 is a vascular disease as well as a respiratory one and have been testing cardiovascular drugs' ability to reduce inflammation and fluid in the lungs.